Search

BackgroundColorectal cancer screening by fecal occult blood testing has been an important public health test and shown to reduce colorectal cancer–related mortality. However, the low participation rate in colorectal cancer screening by the general public remains a problematic public health issue. This fact could be attributed to the complex and unpleasant operation of the screening tool. ObjectiveThis study aimed to validate a novel toilet paper–based point-of-care test (ie, JustWipe) as a public health instrument to detect fecal occult blood and provide detailed results from the evaluation of the analytic characteristics in the clinical validation. MethodsThe mechanism of fecal specimen collection by the toilet-paper device was verified with repeatability and reproducibility tests. We also evaluated the analytical characteristics of the test reagents. For clinical validation, we conducted comparisons between JustWipe and other fecal occult blood tests. The first comparison was between JustWipe and typical fecal occult blood testing in a central laboratory setting with 70 fecal specimens from the hospital. For the second comparison, a total of 58 volunteers were recruited, and JustWipe was compared with the commercially available Hemoccult SENSA in a point-of-care setting. ResultsAdequate amounts of fecal specimens were collected using the toilet-paper device with small day-to-day and person-to-person variations. The limit of detection of the test reagent was evaluated to be 3.75 µg of hemoglobin per milliliter of reagent. Moreover, the test reagent also showed high repeatability (100%) on different days and high reproducibility (>96%) among different users. The overall agreement between JustWipe and a typical fecal occult blood test in a central laboratory setting was 82.9%. In the setting of point-of-care tests, the overall agreement between JustWipe and Hemoccult SENSA was 89.7%. Moreover, the usability questionnaire showed that the novel test tool had high scores in operation friendliness (87.3/100), ease of reading results (97.4/100), and information usefulness (96.1/100). ConclusionsWe developed and validated a toilet paper–based fecal occult blood test for use as a point-of-care test for the rapid (in 60 seconds) and easy testing of fecal occult blood. These favorable characteristics render it a promising tool for colorectal cancer screening as a public health instrument.

Previous studies have suggested that, socially anxious individuals tend to avoid eye contact while looking toward faces.The study designed an emotional faces task consisted of human and comic face stimuli with 6 different emotions (happy,angry, sad, scared, stunned, confused), and recorded the eye movements to examine the hypotheses above. The resultsrevealed that high social anxiety (HSA), medium social anxiety (MSA) and low social anxiety (LSA) individuals have nosignificant difference on total fixation duration of the eyes, nose, and mouth among 6 different emotions. However, whilefocusing on the angry expression, LSA have significantly higher total fixation duration, visit count and area normalizedscore on the nose. It shows that LSA tend to focus on the nose intentionally when a person shows an angry face. Further-more, HSA show lower proportion of eyes to eyes, nose and mouth fixation duration than MSA in happy, sad and stunfaces.

Simple Summary: The ability to predict or detect colorectal cancer (CRC) recurrence early after surgery enables physicians to apply appropriate treatment plans and different follow-up strategies to improve patient survival. A certain portion of CRCs will recur, and current surveillance tools have limitations in the precise and early detection of cancer relapse. Circulating tumor cells (CTCs), cancer cells that are disconnected from the primary tumor and enter the bloodstream, can provide real-time information on disease status. CTCs might become markers not only for predicting CRC recurrence but also for guiding therapy for stage II CRC and monitoring disease relapse in locally advanced rectal cancer patients receiving neoadjuvant therapy. Using CTC subtypes and CTCs combined with clinicopathological factors is an even more powerful way to predict CRC recurrence. The ability to predict or detect colorectal cancer (CRC) recurrence early after surgery enables physicians to apply appropriate treatment plans and different follow-up strategies to improve patient survival. Overall, 30–50% of CRC patients experience cancer recurrence after radical surgery, but current surveillance tools have limitations in the precise and early detection of cancer recurrence. Circulating tumor cells (CTCs) are cancer cells that detach from the primary tumor and enter the bloodstream. These can provide real-time information on disease status. CTCs might become novel markers for predicting CRC recurrence and, more importantly, for making decisions about additional adjuvant chemotherapy. In this review, the clinical application of CTCs as a therapeutic marker for stage II CRC is described. It then discusses the utility of CTCs for monitoring cancer recurrence in advanced rectal cancer patients who undergo neoadjuvant chemoradiotherapy. Finally, it discusses the roles of CTC subtypes and CTCs combined with clinicopathological factors in establishing a multimarker model for predicting CRC recurrence. [ABSTRACT FROM AUTHOR]